EE03661B1 - Vähendatud viskoossusega oftalmoloogiline kompositsioon - Google Patents

Vähendatud viskoossusega oftalmoloogiline kompositsioon

Info

Publication number: EE03661B1
Authority: EE; Estonia
Prior art keywords: amount; pct; weight; viscosity; composition
Prior art date: 1994-03-31

Application number

EE9600120A

Other languages

English (en)

Estonian (et)

Other versions

EE9600120A (et

Inventor

Reunam�ki Timo

Lehmussaari Kari

Vartiainen Eija

Oksala Olli

Alaranta Sakari

Pohjala Esko

Original Assignee

Leiras Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-31

Filing date

1995-03-29

Publication date

2002-04-15

1995-03-29 Application filed by Leiras Oy filed Critical Leiras Oy

1997-04-15 Publication of EE9600120A publication Critical patent/EE9600120A/xx

2002-04-15 Publication of EE03661B1 publication Critical patent/EE03661B1/xx

Links

239000000203 mixture Substances 0.000 title abstract 4
150000003839 salts Chemical class 0.000 abstract 3
229920000642 polymer Polymers 0.000 abstract 2
238000010521 absorption reaction Methods 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
239000000872 buffer Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
229920001477 hydrophilic polymer Polymers 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1
230000002335 preservative effect Effects 0.000 abstract 1
230000001105 regulatory effect Effects 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
239000000080 wetting agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

EE9600120A 1994-03-31 1995-03-29 Vähendatud viskoossusega oftalmoloogiline kompositsioon EE03661B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9401108A SE9401108D0 (sv)	1994-03-31	1994-03-31	Ophthalmic composition I
PCT/FI1995/000166 WO1995026711A1 (en)	1994-03-31	1995-03-29	Ophthalmic composition with decreased viscosity

Publications (2)

Publication Number	Publication Date
EE9600120A EE9600120A (et)	1997-04-15
EE03661B1 true EE03661B1 (et)	2002-04-15

Family

ID=20393511

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9600120A EE03661B1 (et)	1994-03-31	1995-03-29	Vähendatud viskoossusega oftalmoloogiline kompositsioon

Country Status (26)

Country	Link
US (1)	US5710182A (pl)
EP (1)	EP0752847B1 (pl)
JP (1)	JPH10503470A (pl)
KR (1)	KR100365914B1 (pl)
CN (1)	CN1112918C (pl)
AT (1)	ATE202921T1 (pl)
AU (1)	AU694497B2 (pl)
BG (1)	BG63145B1 (pl)
BR (1)	BR9507438A (pl)
CA (1)	CA2186734A1 (pl)
CZ (1)	CZ290987B6 (pl)
DE (2)	DE752847T1 (pl)
DK (1)	DK0752847T3 (pl)
EE (1)	EE03661B1 (pl)
ES (1)	ES2161874T3 (pl)
GR (1)	GR3036763T3 (pl)
HU (1)	HU223071B1 (pl)
MX (1)	MX9603918A (pl)
NO (1)	NO314434B1 (pl)
PL (1)	PL179433B1 (pl)
PT (1)	PT752847E (pl)
RO (1)	RO115409B1 (pl)
RU (1)	RU2139016C1 (pl)
SE (1)	SE9401108D0 (pl)
SK (1)	SK280492B6 (pl)
WO (1)	WO1995026711A1 (pl)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9718568D0 (en)	1997-09-03	1997-11-05	Chauvin Pharmaceuticals Limite	Compositions
AU4808000A (en)	1999-04-28	2000-11-10	Situs Corporation	Drug delivery system
KR100366439B1 (ko) *	2000-02-21	2003-01-09	주식회사 대웅	상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물
US6852688B2 (en)	2000-03-10	2005-02-08	University Of Florida	Compositions for treating diabetic retinopathy and methods of using same
RU2191013C2 (ru) *	2000-10-04	2002-10-20	Федеральное унитарное предприятие "Московский эндокринный завод"	Антиглаукоматозное средство
PT1484054E (pt) *	2002-02-22	2012-11-28	Santen Pharmaceutical Co Ltd	Sistema de administração de fármaco para administração subconjuntival de partículas finas
MXPA04008171A (es) *	2002-02-22	2004-11-26	Pharmacia Corp	Formulacion oftalmica con sistema de goma.
CN100453066C (zh) *	2002-12-04	2009-01-21	参天制药株式会社	利用结膜下储存库的药物释放系统
JP2004196787A (ja) *	2002-12-04	2004-07-15	Santen Pharmaceut Co Ltd	結膜下デポによるドラッグデリバリーシステム
US7947295B2 (en) *	2003-06-13	2011-05-24	Alcon, Inc.	Ophthalmic compositions containing a synergistic combination of two polymers
CA2839847C (en) *	2003-06-13	2016-03-15	Masood A. Chowhan	Ophthalmic compositions containing a synergistic combination of two polymers
WO2005018608A1 (ja) *	2003-08-20	2005-03-03	Santen Pharmaceutical Co., Ltd.	微粒子テノン嚢下投与ドラッグデリバリーシステム
RU2278656C1 (ru) *	2004-11-29	2006-06-27	Уфимский научно-исследовательский институт глазных болезней	Вискоэластик для защиты внутриглазных тканей глаза
TWI367098B (en) *	2004-12-23	2012-07-01	Kowa Co	Treating agent for glaucoma
US7862552B2 (en)	2005-05-09	2011-01-04	Boston Scientific Scimed, Inc.	Medical devices for treating urological and uterine conditions
DE102005035986B4 (de) *	2005-07-28	2009-10-15	Bausch & Lomb Incorporated	Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
RU2340327C1 (ru) *	2007-05-03	2008-12-10	Лев Давидович Раснецов	Офтальмологический гель и способ его приготовления
US20110190323A1 (en) *	2008-08-28	2011-08-04	President And Fellows Of Harvard College	Cortistatin analogues and syntheses thereof
EP2383286A1 (en)	2010-04-30	2011-11-02	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and compositions for treatment of retinal degenerative diseases
TW201309343A (zh) *	2011-02-10	2013-03-01	參天製藥股份有限公司	經改善親水性藥物之藥物移行性之水性組成物
WO2013124477A1 (en)	2012-02-24	2013-08-29	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and compositions for treatment of retinal degenerative diseases
AU2014369834B2 (en)	2013-12-24	2018-12-20	President And Fellows Of Harvard College	Cortistatin analogues and syntheses and uses thereof
WO2016182932A1 (en)	2015-05-08	2016-11-17	President And Fellows Of Harvard College	Cortistatin analogues, syntheses, and uses thereof
EP3302426A4 (en)	2015-05-29	2018-12-05	Sydnexis, Inc.	D2o stabilized pharmaceutical formulations
EP3316889A4 (en)	2015-07-01	2018-11-14	President and Fellows of Harvard College	Cortistatin analogues and syntheses and uses thereof
AR106018A1 (es)	2015-08-26	2017-12-06	Achillion Pharmaceuticals Inc	Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en)	2015-08-26	2017-03-02	Achillion Pharmaceuticals, Inc.	Compounds for treatment of immune and inflammatory disorders
CN109475756A (zh)	2016-02-17	2019-03-15	儿童医疗中心有限公司	Ffa1(gpr40)作为神经血管生成疾病或病症的治疗标靶
CN109790143A (zh)	2016-05-10	2019-05-21	C4医药公司	用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
SG11201811491YA (en)	2016-06-27	2019-01-30	Achillion Pharmaceuticals Inc	Quinazoline and indole compounds to treat medical disorders
WO2018033854A1 (en)	2016-08-15	2018-02-22	Santen Pharmaceutical Co., Ltd.	Ophthalmic composition and a method for treating ocular hypertension and glaucoma
PT3500255T (pt)	2016-08-19	2023-01-10	Orasis Pharmaceuticals Ltd	Composições farmacêuticas oftálmicas e utilizações relacionadas com estas
CN110603252A (zh)	2017-03-01	2019-12-20	艾其林医药公司	用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
US10251875B2 (en) *	2017-05-11	2019-04-09	Nevakar Inc.	Atropine pharmaceutical compositions
CN110769822A (zh)	2017-06-20	2020-02-07	C4医药公司	用于蛋白降解的n/o-连接的降解决定子和降解决定子体
EP3773576A4 (en)	2018-03-26	2021-12-29	C4 Therapeutics, Inc.	Cereblon binders for the degradation of ikaros
US20230022157A1 (en)	2018-08-20	2023-01-26	Achillion Pharmaceuticals, Inc.	Pharmaceutical compounds for the treatment of complement factor d medical disorders
JP7443375B2 (ja)	2018-09-06	2024-03-05	アキリオンファーマシューティカルズ，インコーポレーテッド	医学的障害の治療のための大環状化合物
EP3866773B1 (en)	2018-10-16	2024-08-28	Georgia State University Research Foundation, Inc.	Carbon monoxide prodrugs for the treatment of medical disorders
GB201904125D0 (en)	2019-03-26	2019-05-08	Ge Healthcare Bio Sciences Ab	Method for sanitization of a chromatography column
WO2020210630A1 (en)	2019-04-12	2020-10-15	C4 Therapeutics, Inc.	Tricyclic degraders of ikaros and aiolos
CN115362162A (zh)	2020-02-20	2022-11-18	艾其林医药公司	用于治疗补体因子d介导的障碍的杂芳基化合物
TW202146412A (zh)	2020-03-05	2021-12-16	美商Ｃ４醫藥公司	用於標靶降解brd9之化合物
CN116437913A (zh)	2020-09-23	2023-07-14	艾其林医药公司	用于治疗补体介导的病症的药物化合物
US20240139166A1 (en) *	2021-02-04	2024-05-02	Sydnexis, Inc.	Ophthalmic compositions for presbyopia
EP4088713A1 (en)	2021-05-10	2022-11-16	Warszawskie Zaklady Farmaceutyczne Polfa S.A.	Ophthalmic pharmaceutical composition comprising atropine
EP4088714A1 (en)	2021-05-10	2022-11-16	Warszawskie Zaklady Farmaceutyczne Polfa S.A.	Ophthalmic pharmaceutical composition comprising atropine
CN113786380A (zh) *	2021-09-18	2021-12-14	华北制药股份有限公司	一种硝酸毛果芸香碱眼用凝胶及其制备方法
WO2025160409A1 (en)	2024-01-26	2025-07-31	Flagship Pioneering Innovations V, Inc.	Viral vectors for modulating vegf function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6056684B2 (ja) *	1977-11-07	1985-12-11	東興薬品工業株式会社	点眼剤
RU2000790C1 (ru) *	1987-07-15	1993-10-15	Уфимский научно-исследовательский институт глазных болезней	Глазна мазь
US5252318A (en) *	1990-06-15	1993-10-12	Allergan, Inc.	Reversible gelation compositions and methods of use
FR2678832B1 (fr) *	1991-07-10	1995-03-17	Europhta Sa Laboratoire	Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
RU2056821C1 (ru) *	1993-02-26	1996-03-27	Межотраслевой научно-технический комплекс "Микрохирургия глаза"	Глазные капли "кератоник"

1994
- 1994-03-31 SE SE9401108A patent/SE9401108D0/xx unknown
1995
- 1995-03-29 DE DE0752847T patent/DE752847T1/de active Pending
- 1995-03-29 BR BR9507438A patent/BR9507438A/pt not_active IP Right Cessation
- 1995-03-29 SK SK1239-96A patent/SK280492B6/sk not_active IP Right Cessation
- 1995-03-29 CA CA002186734A patent/CA2186734A1/en not_active Abandoned
- 1995-03-29 DE DE69521686T patent/DE69521686T2/de not_active Expired - Lifetime
- 1995-03-29 PT PT95914362T patent/PT752847E/pt unknown
- 1995-03-29 HU HU9602691A patent/HU223071B1/hu active IP Right Grant
- 1995-03-29 CN CN95192185A patent/CN1112918C/zh not_active Expired - Fee Related
- 1995-03-29 RU RU96119953A patent/RU2139016C1/ru active
- 1995-03-29 ES ES95914362T patent/ES2161874T3/es not_active Expired - Lifetime
- 1995-03-29 US US08/535,037 patent/US5710182A/en not_active Expired - Lifetime
- 1995-03-29 AU AU21389/95A patent/AU694497B2/en not_active Ceased
- 1995-03-29 WO PCT/FI1995/000166 patent/WO1995026711A1/en not_active Ceased
- 1995-03-29 CZ CZ19962865A patent/CZ290987B6/cs not_active IP Right Cessation
- 1995-03-29 PL PL95316584A patent/PL179433B1/pl unknown
- 1995-03-29 DK DK95914362T patent/DK0752847T3/da active
- 1995-03-29 EP EP95914362A patent/EP0752847B1/en not_active Expired - Lifetime
- 1995-03-29 AT AT95914362T patent/ATE202921T1/de active
- 1995-03-29 EE EE9600120A patent/EE03661B1/xx unknown
- 1995-03-29 JP JP7525423A patent/JPH10503470A/ja not_active Ceased
- 1995-03-29 KR KR1019960705391A patent/KR100365914B1/ko not_active Expired - Fee Related
- 1995-03-29 MX MX9603918A patent/MX9603918A/es unknown
- 1995-03-29 RO RO96-01877A patent/RO115409B1/ro unknown
1996
- 1996-09-27 NO NO19964070A patent/NO314434B1/no not_active IP Right Cessation
- 1996-10-16 BG BG100915A patent/BG63145B1/bg unknown
2001
- 2001-09-28 GR GR20010401621T patent/GR3036763T3/el unknown

Also Published As

Publication number	Publication date
BR9507438A (pt)	1997-09-16
GR3036763T3 (en)	2001-12-31
JPH10503470A (ja)	1998-03-31
SE9401108D0 (sv)	1994-03-31
AU694497B2 (en)	1998-07-23
ATE202921T1 (de)	2001-07-15
WO1995026711A1 (en)	1995-10-12
MX9603918A (es)	1997-04-30
CZ290987B6 (cs)	2002-11-13
KR970702024A (ko)	1997-05-13
ES2161874T3 (es)	2001-12-16
RU2139016C1 (ru)	1999-10-10
HUT75666A (en)	1997-05-28
BG100915A (en)	1997-07-31
NO964070D0 (no)	1996-09-27
SK123996A3 (en)	1997-06-04
DE752847T1 (de)	1997-09-04
PT752847E (pt)	2001-12-28
DK0752847T3 (da)	2001-10-22
SK280492B6 (sk)	2000-03-13
KR100365914B1 (ko)	2003-04-16
DE69521686T2 (de)	2002-04-25
EE9600120A (et)	1997-04-15
CN1112918C (zh)	2003-07-02
HU223071B1 (hu)	2004-03-01
RO115409B1 (ro)	2000-02-28
EP0752847A1 (en)	1997-01-15
PL179433B1 (pl)	2000-09-29
HU9602691D0 (en)	1996-11-28
EP0752847B1 (en)	2001-07-11
HK1013953A1 (en)	1999-09-17
BG63145B1 (bg)	2001-05-31
US5710182A (en)	1998-01-20
CN1144477A (zh)	1997-03-05
NO964070L (no)	1996-11-28
NO314434B1 (no)	2003-03-24
DE69521686D1 (de)	2001-08-16
CA2186734A1 (en)	1995-10-12
AU2138995A (en)	1995-10-23
CZ286596A3 (en)	1997-04-16
PL316584A1 (en)	1997-01-20

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2010-02-15	KB4A	Valid patent at the end of a year	Effective date: 20091231
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231

Publication	Publication Date	Title
EE03661B1 (et)	2002-04-15	Vähendatud viskoossusega oftalmoloogiline kompositsioon
SE9401109D0 (sv)	1994-03-31	Opthalmic composition II
US5945121A (en)	1999-08-31	Liposome eye drops
AU625099B2 (en)	1992-07-02	Aqueous antimicrobial ophthalmic solutions
US4440662A (en)	1984-04-03	Cleaning composition for contact lenses
KR960700081A (ko)	1996-01-19	콘택트렌즈 용액 보존 시스템(preservative system for contact lens solutions)
WO1998005365A3 (en)	1998-04-30	Compositions and methods for disinfecting contact lenses and preserving contact lens care products
KR940006575A (ko)	1994-04-25	증가된 안내압 치료를 위한 안구 국소 투여용 약제학적 조성물
DE60012068D1 (de)	2004-08-19	Zusammensetzung mit kontinuierlicher wässeriger Phase, die L-2-Oxothiazolidin- 4-carbonsäure enthält".
DE3625867C2 (de)	1995-10-19	Verwendung von Tetrachlordecaoxid in der Ophthalmologie
AU2001242398A1 (en)	2001-08-27	Contact lens treating method and composition
JPS6217973B2 (pl)	1987-04-21